Investor's Crypto DailyInvestor's Crypto Daily
Font ResizerAa
  • Home
  • Headlines
    • Financial Market News
    • Cryptocurrency News
    • Press Releases
    • My Bookmarks
  • Spotlight Stories
  • Crypto Stock Plays
    • Crypto ETFs, Trusts & Investment Funds
    • Crypto Adjacent Stocks
    • Crypto Futures (Settled in USD)
  • Step Into Crypto
    • Common Crypto Terms
    • Crypto Rules & Regulations
  • Economy
    • Economic News
    • Economic Calendar
  • Join Us
Reading: ACN stock dropped in price after earning: This is a good time to buy ACN shares
Share
Font ResizerAa
Investor's Crypto DailyInvestor's Crypto Daily
  • Home
  • Headlines
  • Spotlight Stories
  • Crypto Stock Plays
  • Step Into Crypto
  • Economy
  • Join Us
Search
  • Home
  • Headlines
    • Financial Market News
    • Cryptocurrency News
    • Press Releases
    • My Bookmarks
  • Spotlight Stories
  • Crypto Stock Plays
    • Crypto ETFs, Trusts & Investment Funds
    • Crypto Adjacent Stocks
    • Crypto Futures (Settled in USD)
  • Step Into Crypto
    • Common Crypto Terms
    • Crypto Rules & Regulations
  • Economy
    • Economic News
    • Economic Calendar
  • Join Us
Follow US
  • Advertise
© 2024 Investor's Crypto Daily. All Rights Reserved.
Investor's Crypto Daily > Blog > Headlines > Financial Market News > ACN stock dropped in price after earning: This is a good time to buy ACN shares
Financial Market News

ACN stock dropped in price after earning: This is a good time to buy ACN shares

Last updated: December 19, 2025 2:25 pm
By Chad McAuley 5 Min Read
Share
SHARE

The Accenture share price had a tough year due to the continued concerns over its business. ACN’s stock price dropped from $392 to $270 after initially reaching a peak of $392. The market cap of ACN has fallen from $250, the high for the first half of the year in February, to $166 billion.

Contents
The stock of Accenture has been hit hard by the market this yearACN: A bullish argumentTechnical analysis of the Accenture Share Price

The stock of Accenture has been hit hard by the market this year

ACN’s stock has been under pressure for the past year. This is similar to other consulting firms like Tata Consultancy and Cognizant.

Accenture, a major IT consultancy, was hit by Elon Musk’s DOGE’s decision to cut back on consulting services provided to the Federal Government. Accenture, one of the largest companies in the IT industry with many government contracts is the reason for this.

The USTR circulated a list with the name of the company in it. The agency warned the EU about the large fines it imposed on American technology firms. The agency hinted at the fact that US investigations and fines would be targeted against these European companies.

Accenture has seen its business slow down this year, as businesses have cut costs due to Donald Trump’s tariffs. The company has seen a rise in demand from companies around the world who are implementing artificial intelligence into their business operations. Recently, it partnered with OpenAI (the largest AI company) and Anthropic.

Recent results show that business is improving for the company. New bookings increased by 12 percent to reach $20.9 billion. This was driven primarily by the AI industry, which saw $2.2 billion of new bookings. Julie Sweet, CEO of the company, stated:

We also deepened our ecosystem partnership to assist clients in realizing value. The results are a reflection of our goal to become the partner that clients choose for reinvention.

Accenture’s revenue increased to $18,7 billion in the first quarter of this year. This is a 6% increase from last year’s same-period figures. However, its operating margin decreased to 15%. Analysts had expected much lower revenue figures.

Both the company’s consulting division and its managed service division reported almost identical numbers. The company’s consulting revenue increased to $9.41billion, and its managed service revenues rose to $9.5billion.

Accenture has maintained its guidance for the full year and expects revenue growth to be between 2%-5%, in constant currencies.

ACN: A bullish argument

Accenture’s stock may do well for a number of reasons in the months to come.

The company is performing well, despite ongoing challenges. Recent results and guidance from analysts are proof of this.

Analysts predict that revenue for the second quarter will reach $17.79 Billion, an increase of 6.79% over the previous year. In the two years following, its annual revenue will be $73.64 and $77.68 respectively. Morgan Stanley raised the average analyst stock price target from $288 to $320. zzz

The company’s second benefit is that it will continue to grow as more companies from all industries invest in AI. The growth of the AI industry could be similar to what occurred when cloud computing was implemented.

The company is now a good deal. The company has an forward PE of 19,8 which is lower than both the median for its sector of 23, and also its average over five years of 27,

The fears about reduced government spending are exaggerated. This means that this company is likely to continue winning more contracts.

Technical analysis of the Accenture Share Price

Source: TradingView

On the daily chart, the ACN share price is currently $270. This represents a rebound from the lows of the past year. The stock price has reached the Fibonacci Retracement of 23.6% at $265.

Stocks have also shown a head-and shoulders pattern inverted, one of the more popular signs for reversal. The stock has moved over the 50-day exponential moving average.

The most probable scenario would be that the stock will continue to rise, and the key next target is $308, which is the Fibonacci Retracement 50% level. This is approximately 14.65% higher than the current price.

The post Accenture Stock Price Dropped After Earnings: Case for Buying ACN Shares may change as new developments unfold.

Click here to read more

You May Also Like:

  • Ratan Tata, the rare businessman loved by all
  • Ratan Tata dies aged 86, legendary leader of India’s…
  • Elon Musk is still supporting Trump despite his…

You Might Also Like

Shares of Sarepta fall by 37% after FDA raises questions about future of gene therapy

Why Addex Therapeutics stock soared 70% on Tuesday

Nvidia’s success is preventing its stock price from rising

Stephanie Link shares her favorite retail stocks following April’s inflation figures

Lululemon misses Q2 sales expectations, stock tanks 10%

Share This Article
Facebook Twitter Email Copy Link Print
Previous Article Coinbase Sues Michigan Illinois and Connecticut over Prediction Market Oversight Battle
Next Article Brazil’s Ibovespa rises on Blue-Chip strength amid Budget Vote, Global Cues
Leave a comment

Click here to cancel reply.

Please Login to Comment.

Stay Connected

TwitterFollow
- Partnered Content -
Ad image

Latest News

KOSPI rebounds as chip stocks recover while Nikkei 225 slides on bond shock
Financial Market News
Michael Saylor’s Strategy Resumes Bitcoin Purchases, Adding $370,000,000 Worth of BTC
Cryptocurrency News
Kalshi Permanently Bans George Santos Over State of the Union Trading
Cryptocurrency News
SpaceX stock gains as Bernstein maintains bullish outlook
Financial Market News
//

We support the traditional finance investor’s journey into the cryptocurrency space, using education and traditional terms. Get involved in crypto directly or through adjacent stocks and funds. Time to get off the sidelines.

– Sponsored Spotlight –

Get Around

  • Home
  • Headline News
  • Spotlight Stories
    New
  • Economy
  • Step Into Crypto

Get Involved

  • Advertise With Us
  • Join Us
    Hot
  • My Bookmarks
  • Privacy Policy & Legal Disclaimer
  • Contact US
2024 Investor's Crypto Daily | InvestorsCryptoDaily.com | Privacy
Welcome Back!

Sign in to your account

Lost your password?